Kelly A. Romano - 31 Mar 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
Glenna Mileson, Attorney-in-fact for Kelly A. Romano
Issuer symbol
ATHA
Transactions as of
31 Mar 2022
Net transactions value
+$104,880
Form type
4
Filing time
01 Apr 2022, 16:40:20 UTC
Previous filing
04 Feb 2022
Next filing
27 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Purchase $104,880 +8,000 +2540% $13.11 8,315 31 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.